OmniSyn unifies target-aware molecular generation and optimization within a synthesis-native LLM framework across the human proteome
Designing target-specific bioactive molecules with actionable synthesis routes for the human proteome holds enormous potential for expanding therapeutic discovery, but remains a challenge. Existing target-aware generative models often depend on protein structures and generate molecules before assessing synthetic feasib...